Symbiox Investment & Trading Company Ltd (NSE: SYMBIOX), ISIN INE653R01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SYMBIOX last traded at ₹1.65 (+4.43%), with a 52-week range of ₹1.36 to ₹3.70 (as of 29 Jul 2026).
Shareholding as of Dec 2025: promoters 3.33%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 66/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.